1Metz C,Cave H,Bertrand AM,et al.NDM French Study Group.Neonatal diabetes mellitus:chromosomal analysis in transient and permanent cases[J].J Pediatr,2002,141(4):483-489.
2Shield JP,Gardner RJ,Wadsworth EJ,et al.Aetiopathology and genetic basis of neonatal diabetes[J].Arch Dis Child Fetal Neonatal Ed,1997,76(1):F39-F42.
4Stanik J,Gasperikova D,Paskova M,et al.Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers[J].J Clin Endocrinol Metab,2007,92(4):1276-1282.
5Wiedemann B,Schober E,Waldhoer T,et al.Incidence of neonatal diabetes in Austria-calculation based on the Austrian Diabetes Register[J].Pediatr Diabetes,2010,11(1):18-23.
6Woolley SL,Saranga S.Neonatal diabetes mellitus:A rare but important diagnosis in the critically ill infant[J].Eur J Emerg Med,2006,13(6):349-351.
7Henquin JC.Pathways in beta-cell stimulus-secretion coupling as targets for therapeutic insulin secretagogues[J].Diabetes,2004,53 (Suppl 3):S48-S58.
9Sagen JV,Raeder H,Hathout E,et al.Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2:patient characteristics and initial response to sulfonylurea therapy[J].Diabetes,2004,53(10):2713-2718.
10Pearson ER,Flechtner I,Njolstad PR,et al.Neonatal Diabetes International Collaborative Group.Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations[J].N Engl J Med,2006,355(5):467-477.
5Kaufman FR, Shaw J. Type 2 diabetes in youth: rates, antecedents, treatment, problems and prevention [ J ]. Pediatr Diabetes, 2007, 8 ( Suppl 9) : 4-6.
6Wei JN, Sung FC, Lin CC, et al. National surveillance for type 2 diabetes mellitus in Taiwan Residents children [ J ]. JAMA, 2003, 290 (10) : 1345-1350.
7. Zeitler P, Hirst K, Pyle L, et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes [ J ] N Engl J Med, 2012, 366(24): 2247-2256.
8Jones KL, Arslanian S, Peterokova VA, et al. Effect of metformin in pediatric patients with type 2 diabetes : a randomized controlled trial [J]. Diabetes Care, 2002, 25 (1): 89-94.
9Gottschalk M, Danne T, Vlajnic A, et al. Glimepiride versus mefformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study [ J ]. Diabetes Care, 2007, 30(4) :790-794.
10Lori Laffel, Nancy Chang, Margaret Grey, et al. Mefformin monotherapy in youth with recent onset type 2 diabetes: experience from the pre-randomization run-in phase of the TODAY study [J]. Pediatric Diabetes, 2012, 13(5) : 385-391.
